Diagnostic utility of allergy tests to predict baked egg and lightly cooked egg allergies compared to double-blind placebo-controlled food challenges.


Journal

Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028

Informations de publication

Date de publication:
09 2023
Historique:
revised: 17 04 2023
received: 23 02 2023
accepted: 14 05 2023
medline: 4 9 2023
pubmed: 7 7 2023
entrez: 7 7 2023
Statut: ppublish

Résumé

Double-blind placebo-controlled food challenges (DBPCFC) are the gold-standard to diagnose food allergy. However, they can cause allergic reactions of unpredictable severity. We assessed accuracy of current and new diagnostic tests compared to DBPCFC to baked egg (BE) and to lightly cooked egg (LCE). Children aged 6 months to 15 years were assessed for possible egg allergy as part of the BAT2 study (NCT03309488). They underwent clinical assessment, skin prick test (SPT), specific IgE (sIgE) and basophil activation test (BAT). The results of the tests were compared with DBPCFC outcomes to both BE and LCE. A total of 150 children underwent DBPCFC to BE, 60 (40%) reacted to and 85 (57%) tolerated BE and 5 (3%) had inconclusive oral food challenges (OFC). Seventy-seven children tolerant to BE had DBPCFC to LCE and 16 reacted. The test within each modality with the best diagnostic performance for BE allergy was as follows: SPT to egg white (EW) (AUC = 0.726), sIgE to EW (AUC = 0.776) and BAT to egg (AUC = 0.783). BAT (AUC = 0.867) was the best test in the younger than 2 years age group. Applying 100% sensitivity and 100% specificity cut-offs, followed by OFC, resulted in 100% diagnostic accuracy. BAT enabled the greatest reduction in OFC (41%). Using sIgE followed by BAT allowed to reduce the number of BATs performed by about 30% without significantly increasing the number of OFC. The best diagnostic test was BAT to egg in terms of diagnostic accuracy and reduction in number of OFC. Using sIgE to EW followed by BAT required fewer BATs with sustained OFC reduction and diagnostic accuracy.

Sections du résumé

BACKGROUND
Double-blind placebo-controlled food challenges (DBPCFC) are the gold-standard to diagnose food allergy. However, they can cause allergic reactions of unpredictable severity. We assessed accuracy of current and new diagnostic tests compared to DBPCFC to baked egg (BE) and to lightly cooked egg (LCE).
METHODS
Children aged 6 months to 15 years were assessed for possible egg allergy as part of the BAT2 study (NCT03309488). They underwent clinical assessment, skin prick test (SPT), specific IgE (sIgE) and basophil activation test (BAT). The results of the tests were compared with DBPCFC outcomes to both BE and LCE.
RESULTS
A total of 150 children underwent DBPCFC to BE, 60 (40%) reacted to and 85 (57%) tolerated BE and 5 (3%) had inconclusive oral food challenges (OFC). Seventy-seven children tolerant to BE had DBPCFC to LCE and 16 reacted. The test within each modality with the best diagnostic performance for BE allergy was as follows: SPT to egg white (EW) (AUC = 0.726), sIgE to EW (AUC = 0.776) and BAT to egg (AUC = 0.783). BAT (AUC = 0.867) was the best test in the younger than 2 years age group. Applying 100% sensitivity and 100% specificity cut-offs, followed by OFC, resulted in 100% diagnostic accuracy. BAT enabled the greatest reduction in OFC (41%). Using sIgE followed by BAT allowed to reduce the number of BATs performed by about 30% without significantly increasing the number of OFC.
CONCLUSIONS
The best diagnostic test was BAT to egg in terms of diagnostic accuracy and reduction in number of OFC. Using sIgE to EW followed by BAT required fewer BATs with sustained OFC reduction and diagnostic accuracy.

Identifiants

pubmed: 37417650
doi: 10.1111/all.15797
pmc: PMC10790315
doi:

Substances chimiques

Allergens 0
Immunoglobulin E 37341-29-0

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2510-2522

Subventions

Organisme : Medical Research Council
ID : G0902018
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_18052
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008517/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T032081/1
Pays : United Kingdom

Informations de copyright

© 2023 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Références

J Allergy Clin Immunol. 2012 Aug;130(2):473-80.e1
pubmed: 22846751
N Engl J Med. 2016 May 5;374(18):1733-43
pubmed: 26943128
J Allergy Clin Immunol. 2021 Aug;148(2):495-505.e14
pubmed: 33675817
J Allergy Clin Immunol Pract. 2013 Jul-Aug;1(4):354-60
pubmed: 24013255
J Allergy Clin Immunol. 2011 Mar;127(3):668-76.e1-2
pubmed: 21377036
Nutrients. 2022 Aug 18;14(16):
pubmed: 36014905
Allergy. 2023 Sep;78(9):2510-2522
pubmed: 37417650
J Allergy Clin Immunol Pract. 2023 Dec 27;:
pubmed: 38157981
BMJ. 2015 Oct 28;351:h5527
pubmed: 26511519
J Allergy Clin Immunol. 2013 Oct;132(4):975-6.e1-5
pubmed: 24001803
Pediatr Allergy Immunol. 2021 Oct;32(7):1482-1489
pubmed: 33955090
J Allergy Clin Immunol. 2022 Sep;150(3):657-665.e13
pubmed: 35597613
J Allergy Clin Immunol. 2014 Feb;133(2):492-9
pubmed: 24636473
J Allergy Clin Immunol. 2016 May;137(5):1477-1486.e8
pubmed: 26896232
J Allergy Clin Immunol Pract. 2015 Jan-Feb;3(1):13-23; quiz 24
pubmed: 25577613
J Allergy Clin Immunol Pract. 2022 Jan;10(1):1-9
pubmed: 34530176
Ann Allergy Asthma Immunol. 2016 May;116(5):415-9
pubmed: 26809899
Clin Exp Allergy. 2012 Aug;42(8):1197-205
pubmed: 22805467
Br J Nutr. 2022 Dec 28;128(12):2453-2463
pubmed: 35109944
Clin Exp Allergy. 2013 Oct;43(10):1189-95
pubmed: 24074337
Pediatr Allergy Immunol. 2013 Aug;24(5):450-5
pubmed: 23773122
Int Arch Allergy Immunol. 2022;183(3):249-261
pubmed: 34818647
J Allergy Clin Immunol. 2014 Sep;134(3):645-52
pubmed: 25065721
N Engl J Med. 2015 Feb 26;372(9):803-13
pubmed: 25705822
J Allergy Clin Immunol. 2012 Mar;129(3):739-47
pubmed: 22277199
Food Chem. 2021 Nov 15;362:129879
pubmed: 34118511
Pediatr Allergy Immunol. 2014 Dec;25(8):740-6
pubmed: 25251921
Allergy. 2019 Feb;74(2):318-326
pubmed: 30035811
J Allergy Clin Immunol. 2020 Aug;146(2):344-355
pubmed: 32311390
Pediatr Allergy Immunol. 2014 Nov;25(7):657-61
pubmed: 25298203
Pediatr Allergy Immunol. 2022 Feb;33(2):e13739
pubmed: 35212037
Allergy. 2023 Nov 27;:
pubmed: 38009299

Auteurs

Marta Krawiec (M)

Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, UK.

Suzana Radulovic (S)

Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, UK.

Ru-Xin Foong (RX)

Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, UK.
Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Andreina Marques-Mejias (A)

Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, UK.

Irene Bartha (I)

Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, UK.

Matthew Kwok (M)

Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Zainab Jama (Z)

Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Faye Harrison (F)

Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Cristian Ricci (C)

Africa Unit for Transdisciplinary Health Research (AUTHeR), North-West University, Potchefstroom, South Africa.

Gideon Lack (G)

Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, UK.
Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

George Du Toit (G)

Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, UK.

Alexandra F Santos (AF)

Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, UK.
Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH